Regarding CD133-positive CTCs and prognosis, Pilati et al. analyzed 50 CRC cases with liver metastases and reported that CD133-positive cases had a poorer prognosis than did CD133-negative cases [53]. This evidence concerns the gene PROM1 and colorectal carcinoma.